Trial Profile
Asthma control in patients with severe asthma treated with omalizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 31 Aug 2015 New trial record